Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 74.70
-1.10 (-1.45%)
At close: Mar 27, 2026
Pharmanutra Revenue
In the year 2025, Pharmanutra had annual revenue of 133.97M EUR with 15.34% growth. Pharmanutra had revenue of 39.01M in the quarter ending December 31, 2025, with 21.17% growth.
Revenue
133.97M
Revenue Growth
+15.34%
P/S Ratio
5.35
Revenue / Employee
985.06K
Employees
136
Market Cap
717.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 133.97M | 17.82M | 15.34% |
| Dec 31, 2024 | 116.15M | 15.44M | 15.33% |
| Dec 31, 2023 | 100.71M | 17.64M | 21.24% |
| Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
| Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 487.08M |
| Svas Biosana | 134.95M |